Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

NCT04243954 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cancer Pain

Interventions

DRUG: PCA IV Hydromorphone (continuous dose = 0)
DRUG: PCA IV Hydromorphone (continuous dose ≠ 0)
DRUG: Oral morphine

Sponsor

Fujian Cancer Hospital